Insider files Form 144 to sell 8,148 NRIX shares

Christine Ring reported a Form 144 covering 8,148 common shares issuable from Restricted Stock Units dated 05/02/2022, to be sold through Morgan Stanley Smith Barney LLC.

Rhea-AI Filing Summary

Christine Ring reported a Form 144 covering 8,148 common shares issuable from Restricted Stock Units dated 05/02/2022, to be sold through Morgan Stanley Smith Barney LLC. The filing lists multiple recent 10b5-1 sales by Ms. Ring on 12/18/2025, 01/20/2026, and 02/09/2026, with per-trade proceeds shown.

Insights

Securities Compliance Counsel

Form 144 documents planned sale of shares from RSUs and confirms recent 10b5-1 trades.

This filing lists 8,148 common shares tied to Restricted Stock Units dated 05/02/2022 and identifies Morgan Stanley Smith Barney LLC as the broker-dealer. The excerpt shows recent 10b5-1 sales on 12/18/2025, 01/20/2026, and 02/09/2026 with individual proceeds recorded.

Compliance implications are routine: the filing records planned dispositions under Rule 144 and documents executed 10b5-1 transactions. Subsequent filings would disclose completion or additional trades if required.

Corporate Governance Analyst

Insider sales were processed under trading plan; disclosure is administrative.

The record ties the securities to Restricted Stock Units granted on 05/02/2022 and lists per-trade proceeds: 67,314.15, 69,273.11, 101,860.92, and 135,757.90. The filing is consistent with planned disposals under a 10b5-1 arrangement.

Material impact appears limited; investor-relevant follow-ups would be additional Form 4/144 updates if further sales occur or if timing/volumes change.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 04:33 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001817199
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NURIX THERAPEUTICS INC
SEC File Number	001-39398
Address of Issuer	1600 Sierra Point Parkway Brisbane CALIFORNIA 94005
Phone	4156605320
Name of Person for Whose Account the Securities are To Be Sold	CHRISTINE RING
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	8148	130123.56	102843012	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/02/2022	Restricted Stock Units	Issuer			8148	05/02/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	02/09/2026	8148	135757.90
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	02/09/2026	6113	101860.92
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	01/20/2026	3760	69273.11
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	12/18/2025	3760	67314.15

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 05/02/2022 through 01/30/2025
Date of Notice	03/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christine Ring
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)